Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Capital Expenditures Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Capital Expenditures
-$283k
CAGR 3-Years
57%
CAGR 5-Years
-23%
CAGR 10-Years
-12%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Capital Expenditures
-$3m
CAGR 3-Years
-176%
CAGR 5-Years
1%
CAGR 10-Years
-15%
Repare Therapeutics Inc
NASDAQ:RPTX
Capital Expenditures
-$1.9m
CAGR 3-Years
5%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Capital Expenditures
-CA$605.2k
CAGR 3-Years
-179%
CAGR 5-Years
13%
CAGR 10-Years
-19%
Spectral Medical Inc
TSX:EDT
Capital Expenditures
-CA$213k
CAGR 3-Years
25%
CAGR 5-Years
-16%
CAGR 10-Years
-7%

See Also

What is Aurinia Pharmaceuticals Inc's Capital Expenditures?
Capital Expenditures
-283k USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Capital Expenditures amounts to -283k USD.

What is Aurinia Pharmaceuticals Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-12%

Over the last year, the Capital Expenditures growth was 64%. The average annual Capital Expenditures growth rates for Aurinia Pharmaceuticals Inc have been 57% over the past three years , -23% over the past five years , and -12% over the past ten years .

Back to Top